Global Health Tech Unicorns

The Complete List of Global Health Tech Unicorns

Global Health Tech Unicorns

A unicorn startup or unicorn company is a private company with a valuation over $1 billion USD. Unicorns are โ€˜startupsโ€™, i.e they do not include post-exit, acquired or listed companies, nor do they include โ€˜matureโ€™ incumbents.

As of 1 February 2023, there are 140 HealthTech Unicorns around the world who are now collectively valued at $320B+

Recent Health Tech Unicorn Developments

๐Ÿ‡บ๐Ÿ‡ฒ Komodo raised a further $200M in a venture round in December 2022.

๐Ÿ‡บ๐Ÿ‡ฒ Maven Clinic ($90M) and DispatchHealth ($330M) both went through Series E rounds in November 2022.ย 

๐Ÿ‡บ๐Ÿ‡ฒ Saliogen Therapeutics raised $115M in a Series B round in November 2022.ย 

๐Ÿ‡บ๐Ÿ‡ฒ Transcarentโ€™s Series C round generated $200M in November 2022 while Athelas ($132M), Athletic Greens ($115M) and Tempus ($100M) all had successful venture rounds in the same month.ย 

๐Ÿ‡บ๐Ÿ‡ฒ Orna Therapeutics raised $221M in a Series B in August 2022 with Nimble RX ($14.7M venture round), Owkin ($80M Series B), Resilience ($625M Series D) and BostonGene ($150M Series B) all raised capital in the US market in June 2022.

๐Ÿ‡ธ๐Ÿ‡ฌ Biofourmis raised $300M in a Series D round in April 2022.ย 

๐Ÿ‡บ๐Ÿ‡ฒ Nexhealth raised $125M in a Series C round in April 2022 with Reify Health also raising $220M in a Series D in the same month.

๐Ÿ‡ซ๐Ÿ‡ฎ Oura raised capital in April 2022 in an undisclosed series.ย 

๐Ÿ‡บ๐Ÿ‡ฒ Clarify Health raised $150M in a Series D round in April 2022.ย 

๐Ÿ‡บ๐Ÿ‡ฒ IntelyCare ($115M) and Tessera Therapeutics ($300M) both underwent Series C rounds in April 2022 with Alzheon also raised $50M in a Series D.ย 

๐Ÿ‡บ๐Ÿ‡ฒ ConcertAI raised $150M in a Series C in March 2022.

๐Ÿ‡ซ๐Ÿ‡ท Doctolib raised $549M in a Series F in March 2022.ย 

๐Ÿ‡บ๐Ÿ‡ฒ Somatus ($325M) and Omada Health ($192M) both underwent Series E rounds in February 2022, with Ro ($150M) and Kallyope ($236M) both raising Series D rounds the same month.ย 

๐Ÿ‡บ๐Ÿ‡ฒ HealthCare.com raised $31M as a Series C round in February 2022.

๐Ÿ‡จ๐Ÿ‡ฑ Betterfly raised $125M as a Series C found in February 2022.ย ย ย 

๐Ÿ‡บ๐Ÿ‡ฒ Alto Pharmacy ($200M Series E), Lyra Health ($235M Series F), Wheel Health ($150M Series C), Commure ($154M Series D) and Freenome ($290M) all raised capital in US market in January 2022.

๐Ÿ‡จ๐Ÿ‡ณ Hui Sheng Bio-Pharmaceutical raised $85M as a Series A round in January 2022.

๐Ÿ‡บ๐Ÿ‡ฒ Eikon Therapeutics raised $518M as a Series B round in January 2022.ย 

๐Ÿ‡ซ๐Ÿ‡ท Alan raised $196M in a Series E round in January 2022.ย 

๐Ÿ‡บ๐Ÿ‡ฒ Incredible Health raised $80M in a Series B round in January 2022.ย 

๐Ÿ‡บ๐Ÿ‡ฒ Clipboard Health ($30M Series C), Synthego ($200M Series E) and Viz.ai (Series D) all raised capital in US market in January 2022.ย 

๐Ÿ‡จ๐Ÿ‡ณ Xuanzhu Pharma raised $100M in a Series B round in January 2022.

๐Ÿ‡บ๐Ÿ‡ฒ Bellabeat raised capital in a Series C round in January 2022.ย 

๐Ÿ‡จ๐Ÿ‡ณ CareBridge raised $140M in a venture round in January 2022.

๐Ÿ‡จ๐Ÿ‡ญMindmaze ($105M) and Modernizing Medicine ($53.4M) raised capital in venture rounds in January 2022.

๐Ÿ‡จ๐Ÿ‡ณ Tebra raised $72M as a Series B in January 2022.โ€

The Complete List of Global Health Tech Unicorns

Company

Country

Industry

Last Round

Type

Valuation

United States

Health Insurance

Oct 2021

$1.15B Series D

$12.7B

United States

Health Discovery

Apr 2021

$120M VC Round

$12.4B

United States

Drug Production

Jun 2022

$625M Series D

$9.0B

United States

Precision Medicine

Oct 2022

$275M Venture Round

$8.0B

United States

Precision Medicine

Jan 2021

$830M PE Round

$7.8B

United States

Health Records

Jul 2021

Venture Round

$7.0B

United States

Telehealth

Feb 2022

$150M Series D

$7.0B

China

Telehealth

Jan 2021

$411M Series F

$7.0B

France

Bookings & Referalls

Mar 2022

$549M Series F

$6.4B

United States

Hardware

Oct 2021

$600M Series E

$6.2B

United States

Analytics

Nov 2021

$100M Series F

$6.1B

United States

Mental Health

Jan 2022

$235M Series F

$5.6B

United States

Health Insurance

Sep 2021

$400M Series D

$5.7B

China

Precision Medicine

Jan 2022

$85M Series A

$5.0B

United States

Mental Health

Dec 2021

$300M Series C

$4.8B

United States

Clinical Trials

Apr 2022

$220M Series D

$4.8B

United States

Population Health

Nov 2021

$100M Series E

$4.6B

United States

Analytics

Jun 2021

$400M Series H

$4.0B

Canada

Health Records

Jan 2021

PE Growth Round

$4.0B

United States

Diagnosis Tech

Mar 2021

$12.6M Venture Round

$4.0B

China

Chronic Care

Dec 2021

$514 Milion Series E

$3.9B

United States

Health Discovery

Aug 2019

Undisclosed

$3.8B

China

Health Discovery

Nov 2021

$300M Series C

$3.7B

United States

Wellbeing

May 2021

$540M Series F

$3.7B

United States

Analytics

Jan 2022

$154M Series D

$3.5B

Germany

Devices

Dec 2019

$106.9M Debt

$3.5B

India

Pharmacies

Nov 2021

Private Equity

$3.4B

United States

Analytics

Mar 2021

$220M Series E

$3.3B

United States

Practice Management

Mar 2021

$200M Series D

$3.2B

United States

Health Discovery

Jan 2022

$518M Series B

$3.2B

United States

Analytics

Dec 2021

$150M Series E

$3.1B

United States

Telehealth

Jul 2021

$350M Series D

$3.0B

United Kingdom

Health Robotics

Jun 2021

$600M Series D

$3.0B

France

Health Insurance

Jan 2022

$196M Series E

$2.9B

United States

Decision Support

Jan 2022

$290M PE Round

$2.6B

Finland

Wearables

Apr 2022

VC Round

$2.6B

United States

Chronic Care

Feb 2022

$325M Series E

$2.5B

Singapore

Precision Medicine

Jun 2021

Venture Round

$2.4B

United States

Health Discovery

Mar 2021

$400M Series C

$2.4B

United States

Clinical Trials

Oct 2021

$340M Series D

$2.1B

United States

Devices

Jul 2021

$205M Series C

$2.1B

China

Wearables

Feb 2022

PE Round

$2.1B

Sweden

Telehealth

Apr 2021

$319M Series D

$2.0B

United States

Mental Health

Sep 2021

$190M Series C

$2.0B

United States

Chronic Care

Nov 2021

$163M Series D

$2.0B

United States

Primary Care

Jan 2021

$100M Series D

$1.9B

United States

Mental Health

Dec 2020

$75M Series C

$1.9B

United States

Clinical Insights

Mar 2022

$150M Series C

$1.9B

China

Physical Fitness

Jan 2021

$360M Series F

$1.9B

United States

Chronic Care

Apr 2021

$133M Series D

$1.9B

United States

Precision Medicine

Oct 2021

$100M Series C

$1.8B

United States

Bookings & Referalls

Aug 2015

$130M Series D

$1.8B

United States

Home Health

Mar 2021

$200M Series D

$1.7B

United States

Staffing

Aug 2022

$80M Series B

$1.7B

China

Health Insurance

Dec 2020

$305M Series E

$1.7B

United States

Genomics

Jan 2022

$115M Series B

$1.7B

United States

Genomics

Apr 2022

$300M Series C

$1.7B

United States

Bookings & Referalls

Mar 2021

$150M Series C

$1.7B

United States

Physical Fitness

Nov 2021

$145M Series F

$1.6B

United States

Genomics

Jun 2021

$276 Series C

$1.6B

India

Diagnosis Tech

Sep 2022

$85M Venture Round

$1.6B

United States

Bookings & Referalls

Nov 2022

$200M Series C

$1.6B

United States

Pharmacies

Oct 2021

$142M Series D

$1.6B

United States

Clinical Insights

Dec 2020

$700M VC Round

$1.6B

United States

Chronic Care

Jan 2022

$132M VC Round

$1.5B

United States

Health Insurance

May 2021

$280M Series F

$1.5B

China

Health Robotics

Nov 2021

$200M Series C

$1.5B

United States

Decision Support

Jun 2019

$65M Series E

$1.5B

United States

Telehealth

Jan 2021

$132M Series E

$1.5B

United States

Drug Production

Aug 2022

$221M Series B

$1.5B

China

Diagnostics Tech

Aug 2021

$100M Series D

$1.5B

United States

Physical Fitness

Nov 2020

$110M Series F

$1.5B

United States

Analytics

Apr 2022

$150M Series D

$1.4B

United States

Precision Medicine

Nov 2021

$370M Series B

$1.4B

United States

Pharmacies

Jun 2022

$15M Venture Round

$1.4B

United States

Practice Management

Dec 2021

$110M Series A

$1.4B

United States

Bookings & Referalls

Nov 2021

$150M Series D

$1.4B

India

Telehealth

Dec 2021

$96M Series E

$1.4B

United States

Mental Health

Jan 2021

$150M Series C

$1.4B

China

Devices

May 2021

$188M Series B

$1.4B

China

Pharmacies

Jul 2021

$270M Series E

$1.4B

United States

Health Discovery

Apr 2022

$50M Series D

$1.3B

United States

Nutrition & Supp

Jan 2022

$115M VC Round

$1.3B

United States

Benefits

Feb 2022

$125M Series C

$1.3B

United States

Staffing

Jan 2022

$30M Series C

$1.3B

United States

Devices

Oct 2022

$300M PE Round

$1.3B

United States

Point of Care Testing

Mar 2021

$200M Series E

$1.3B

United States

Telehealth

Dec 2020

$175M Series D

$1.3B

United States

Social Care

Oct 2021

$70M Series E

$1.3B

United States

Genomics

Apr 2021

$150M Series E

$1.3B

United States

Clinical Insights

Jun 2022

$80M Series B

$1.3B

United States

Hospitals

Mar 2021

$168M Series D

$1.2B

United States

Social Care

Oct 2021

$219M Series B

$1.2B

China

Equipment

Mar 2021

$77M Series D

$1.2B

United States

Precision Medicine

Feb 2022

$236M Series D

$1.2B

Israel

Imaging

Apr 2021

$136M Venture Series

$1.2B

United States

Mental Health

Feb 2021

$74M Series D

$1.2B

China

Hospitals

Mar 2021

Series D

$1.2B

United States

Genomics

Jan 2022

$200M Series E

$1.2B

China

Clinical Insights

Sep 2020

$176M Venture Round

$1.2B

United States

Practice Management

Jan 2022

Series D

$1.2B

United States

Staffing

Apr 2022

$115M Series C

$1.1B

United States

Benefits

Mar 2021

$100M Series C

$1.1B

China

Precision Medicine

Jan 2022

$100M Series B

$1.1B

United States

Pharmacies

Jan 2022

$200M Series E

$1.0B

South Korea

Health Discovery

May 2019

-

$1.0B

United States

Wearables

Jan 2022

Series C

$1.0B

Singapore

Analytics

Apr 2022

$320M Series D

$1.0B

United States

Decision Support

Apr 2022

$150M Series B

$1.0B

United States

Remote Monitoring

Dec 2021

$100M Series B

$1.0B

United States

Pharmacies

Apr 2021

$300M Series D

$1.0B

United States

Health Insurance

Jun 2022

$140M Venture Round

$1.0B

France

Remote Monitoring

Oct 2021

$150M PE Round

$1.0B

China

Clinical Trials

Jul 2021

$50M Series C

$1.0B

China

Primary Care

Apr 2018

$100M Series D

$1.0B

United States

Analytics

Mar 2021

$153M Series E

$1.0B

China

Physical Fitness

Apr 2021

$300M Series B

$1.0B

United States

Physical Fitness

Jun 2019

$300M Series D

$1.0B

China

Genomics

Jun 2018

$141.77M Series A

$1.0B

Canada

Practice Management

Dec 2021

$70M Series C

$1.0B

Ireland

Diagnosis Tech

Sep 2022

$20M Series D

$1.0B

China

Health Records

Jul 2018

$151M Series D

$1.0B

United States

Decision Support

May 2021

$165M Series C

$1.0B

United States

Genomics

Sep 2021

$150M Series D

$1.0B

United States

Telehealth

Aug 2021

$110M Series D

$1.0B

China

Pharmacies

Aug 2021

$232M Series F

$1.0B

Switzerland

Specialist Care

Feb 2022

$105M Venture Series

$1.0B

Switzerland

Health Records

Feb 2022

$53.4M Venture Series

$1.0B

United States

Bookings & Referalls

Apr 2022

$125M Series C

$1.0B

United States

Chronic Care

Feb 2022

$192M Series E

$1.0B

United States

Genomics

Jun 2020

$192M Series D

$1.0B

Israel

Wearables

Feb 2018

$30.4M VC Round

$1.0B

United States

Health Insurance

Jan 2021

$125M Series C

$1.0B

United States

Bookings & Referalls

Jul 2022

$72M Series B

$1.0B

United States

Chronic Care

Jun 2021

$140M Series C

$1.0B

United States

Clinical Trials

Sep 2021

$156M Series C

$1.0B

United States

Lab Testing

Jun 2022

$35M Series E

$1.0B

United States

Telehealth

Jan 2022

$150M Series C

$1.0B

United States

Physical Fitness

Sep 2020

$450M Series C

$1.0B

Ready to get started?

Get a personalized walkthrough of HolonIQ's Global Intelligence Platform.

arrow right

Health Tech Unicorn Change Log

Changes to the above list, older than 12 months are published below.

โ€Pristyn Care and Cadence Solutions joined the list in Dec 2021.

โ€EQRx left the list in Dec 2021 via IPO.

โ€Pear Therapeutics was acquired by Thimble Point (SPAC) in Dec 2021.

โ€Abogen, SWORD Health, Curefit and Papa joined the list in Nov 2021.

โ€Elemy, Dental Monitoring, and Truepill joined the list in Oct 2021.

โ€VillageMD was acquired by Walgreens Boots Alliance in Oct 2021.

โ€Babylon Health and Oxford Nanopore Technologies left the list in Oct 2021 via IPO.

โ€Spring Health, Mammoth Biosciences and TrialSpark joined the list in Sep 2021.

โ€Ginkgo BioWorks left the list in Sep 2021 via IPO.

โ€Maven Clinic joined the list in Aug 2021.

โ€Grail was acquired by Illumina in Aug 2021.

โ€Rani Therapeutics, Lyell Immunopharma and Brii Biosciences left the list in Jul 2021 via IPO.

โ€PharmEasy, Prime Medicine, Cerebral, SonderMind, Carbon Health, Yaoshibang and dMed Biopharmaceutical joined the list in Jun โ€“ Jul 2021.

โ€ATAI Life Sciences and Bright Health left the list in Jun 2021 via IPO.

โ€Roivant Sciences left the list in May 2021 via IPO.

โ€Capsule, KRY, Caris Life Sciences, Collective Health, Noom, Valgen Medtech, Fiture joined the list in Apr โ€“ May 2021.

โ€Outcome Health was acquired by PatientPoint in Mar 2021.

โ€Aledade, EQRx, Innovaccer, ATAI Life Sciences, Brii BioSciences, Evidation Health, Ginger, Komodo Health, Radiology Partners, Rightway, Unite Us, DispatchHealth, Pear Therapeutics, Insitro and Shulan Health joined the list in Jan โ€“ Mar 2021.

โ€Recursion Pharmaceuticals left the list in Apr 2021 via IPO.

โ€Oscar Health left the list in Mar 2021 via IPO.

โ€Sema4 was acquired by Casdin Capital and Corvex Management (SPAC) in Feb 2021.

โ€23andMe was acquired by Virgin Galactic Acquisition Corporation (SPAC) in Feb 2021.

โ€Clover Health left the list in Jan 2021 via IPO.

Latest Insights

Global Insights from HolonIQโ€™s Intelligence Unit.Powered by our Global Impact Intelligence Platform.

Sign up for our free weekly newsletters

Join 80,000+ free weekly newsletter subscribers.